UT Health San Antonio physician-scientists are pioneering world-class research in diabetes and kidney diseases and other metabolic disorders and translating discoveries as they educate our next generation of physician-scientists.
Carolina Solis-Herrera, M.D.
2018 Voelcker Fund Young Investigator Award
Under the leadership of Dr. Kumar Sharma, holder of the L. David Hillis, M.D. Endowed Chair, the Division of Nephology has been awarded several large NIH grants, including an NIH funded Kidney Precision Medicine Tissue Interrogation grant.
UT Health San Antonio is the premier site for localizing molecules in human kidney biopsies, redefining causes of common, and rare, kidney disease.
Ralph DeFronzo, M.D., holder of the Joe R. and Teresa Lozano Long Distinguished Chair in Diabetes and 2017 Harold Hamm International Prize Laureate, is ranked among the Top 6 experts of type 2 diabetes mellitus worldwide according to Expertscape.
Kumar Sharma, M.D., professor and chief of nephrology at UT Health San Antonio, was recently awarded a $1.4 million Translational STARs award from The University of Texas System to establish a Center for Renal Precision Medicine at UT Health San Antonio.
Results of a recently completed clinical trial of a potential drug to treat Type 2 diabetes in children were announced April 28 at the Pediatric Academic Societies 2019 meeting in Baltimore, Maryland. The New England Journal of Medicine also published the findings.
Podiatrist and inventor, Dr. Thomas Zgonis, leads a multidisciplinary team that cares for patients with diabetes. The team of physicians and specialists aims to reduce the high rates of diabetic complications in San Antonio and avoid amputations if possible.
Dr. Espinoza and her team are conducting a major NIH-funded study to test metformin as a novel intervention for the prevention of fraility, a clinical geriatric syndrome of progressive physical and physiologic decline that is known to increase risk for multiple adverse outcomes with aging.